Table 1 Baseline characteristics of study subjects stratified by fatty liver index.
Total (n = 8,048,055) | Fatty liver index group | |||
|---|---|---|---|---|
0–30 (n = 5,309,434) | 30–60 (n = 1,814,124) | ≥ 60 (n = 924,497) | ||
Age | 46.7 ± 14.1 | 45.4 ± 14.4 | 50.0 ± 13.5 | 47.3 ± 12.7 |
Men | 52.0 | 40.9 | 69.5 | 81.6 |
Height (cm) | 163.6 ± 9.2 | 162.3 ± 9.0 | 165.1 ± 9.4 | 167.6 ± 8.7 |
Weight (kg) | 63.4 ± 11.5 | 58.6 ± 8.7 | 69.7 ± 8.8 | 78.6 ± 10.8 |
BMI (kg/m2) | 23.6 ± 3.2 | 22.2 ± 2.4 | 25.5 ± 2.2 | 27.9 ± 3.0 |
Waist circumference (cm) | 79.8 ± 9.1 | 75.5 ± 7.0 | 85.9 ± 5.4 | 92.1 ± 6.8 |
Systolic BP (mmHg) | 122.0 ± 14.9 | 119.1 ± 14.3 | 126.5 ± 14.3 | 129.9 ± 14.5 |
Diastolic BP (mmHg) | 76.0 ± 9.9 | 74.1 ± 9.5 | 78.8 ± 9.5 | 81.5 ± 9.9 |
Fasting glucose (mg/dL) | 96.5 ± 22.1 | 93.2 ± 17.9 | 100.7 ± 25.1 | 106.7 ± 31.4 |
Total cholesterol (mg/dL) | 195.2 ± 36.5 | 189.2 ± 34.4 | 204.0 ± 36.6 | 212.7 ± 38.8 |
Triglyceride (mg/dL) | 108 (74–160) | 87 (64–118) | 154 (117–204) | 226 (165–313) |
GGT (mg/dL) | 23 (16–37) | 19 (14–25) | 35 (25–50) | 61 (40–97) |
AST (mg/dL) | 23 (19–28) | 22 (19–26) | 25 (21–30) | 30 (24–38) |
ALT (mg/dL) | 20 (15–29) | 18 (14–23) | 26 (20–36) | 37 (27–53) |
Hypertension | 24.1 | 17.1 | 34.9 | 43.3 |
Diabetes mellitus | 7.9 | 4.7 | 12.0 | 17.8 |
Dyslipidemia | 17.6 | 12.1 | 25.2 | 33.9 |
CKD (eGFR ≤ 60 mL/min/1.73 m2) | 5.8 | 5.3 | 6.9 | 6.3 |
Smoking status | ||||
Non-smoker | 62.3 | 70.5 | 50.2 | 38.6 |
Ex-smoker | 13.3 | 10.3 | 18.6 | 19.9 |
Current smoker | 24.5 | 19.2 | 31.2 | 41.6 |
Alcohol consumption | ||||
Non-drinker | 54.2 | 59.0 | 48.6 | 37.4 |
Mild (0–30 g/day) | 45.8 | 41.0 | 51.4 | 62.6 |
Regular exercise | 51.0 | 49.9 | 52.6 | 54.2 |
Low income | 27.0 | 28.7 | 24.1 | 23.4 |
